Search
Now showing items 1-10 of 24
Cardiac dysfunction among HIV infected children on combination antiretroviral therapy attending joint clinical research centre, Kampala, Uganda.
(Makerere University, 2013)
Introduction
Human Immunodeficiency virus still remains a global problem. Cardiac dysfunction is highly prevalent among symptomatic ART naïve HIV infected children with advanced disease.
Earlier studies have described ...
Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda.
(Elsevier Ireland, 2013)
Objective: To determine factors associated with an unknown HIV serostatus among pregnantwomen admitted in
labor to Mulago Hospital, Kampala, Uganda. Methods: In total, 665 pregnant women admitted to Mulago Hospital
were ...
Cognitive dysfunction among HIV positive and HIV negative patients with psychosis in Uganda
(Public Library of Science, 2012)
Background: Cognitive impairment is an established phenomenon in HIV infected individuals and patients that have
psychosis. However there is need to establish the severity of the impairment if patients are co morbid with ...
Antiretroviral therapy improves cognitive impairment in HIV individuals in Sub-Saharan Africa
(American Academy of Neurology (AAN), 2006)
Abstract—Background: Highly active antiretroviral therapy (HAART) can improve cognitive performance in some patients
with HIV-associated cognitive impairment in the United States. The effect of HAART on HIV dementia ...
In vivo PPD reactivity and associated factors among HIV positive patients on HAART at the Makerere University Infectious Diseases Clinic.
(2009-08)
BACKGROUND:
It is estimated that a third of the world’s population is infected with tuberculosis (TB).
This epidemic is fueled by HIV, with reactivation rates of 8-10% / year and overall lifetime risk of 30% in HIV ...
VS411 Reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics
(PLoS One, 2012)
Background: A new class of antiretrovirals, AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs), has been proposed as a disease-modifying therapy to both reduce Human Immunodeficiency Virus Type 1 (HIV-1) RNA levels ...
Human immunodeficiency virus neurological complications: An overview of the Ugandan experience.
(Journal of NeuroVirology, 2005)
Sub-Saharan Africa, which has about 12% of the global population, is
home to almost 70% of individuals infected with human immunodeficiency
virus/acquired immunodeficiency syndrome (HIV/AIDS). A recent survey by
the ...
Dissertation barriers to timely initiation of antiretroviral therapy among HIV infected children admitted to mulago hospital paediatric wards.
(2007-08)
BACKGROUND:
The median survival of HIV infected children in the absence of treatment is 2 years, thus early initiation of ART is desirable.
In Uganda, ART is now being provided free of charge. However, some children still ...
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy
(Lippincott Wilkins & Williams, 2011)
Background: Tuberculosis-HIV (TB-HIV) coinfection remains an
important cause of mortality in antiretroviral therapy (ART)
programs. In a cohort of TB-HIV–coinfected patients starting
ART, we examined the incidence and ...
Prevalence and factors associated with non-adherence to HAART among HIV-Positive women in reproductive age in Kayunga District
(2009-05)
Introduction: Globally approximately 40.3million people are infected with HIV, of which more 25.8million are in sub-Sahara Africa in 2007. Women living in sub-Saharan Africa are more affected by HIV/AIDS than any other ...